CA Stock MarketDetailed Quotes

CSPN CareSpan Health Inc

Watchlist
  • 0.020
  • 0.0000.00%
15min DelayMarket Closed Dec 13 16:00 ET
952.32KMarket Cap-1.43P/E (TTM)

CareSpan Health Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
84.00%-49.93K
17.01%-284.29K
141.47%267.1K
27.41%-1.64M
-130.26%-342.62K
73.99%-312.03K
71.53%-342.55K
34.97%-644K
22.22%-2.26M
236.76%1.13M
Net income from continuing operations
60.30%-160.06K
17.26%-395.78K
184.61%439.97K
35.23%-2.03M
-604.87%-632.85K
70.39%-403.22K
61.24%-478.36K
22.43%-520K
54.22%-3.14M
105.07%125.35K
Operating gains losses
--0
--0
---170.35K
97.62%-36.56K
----
----
----
----
-592.34%-1.54M
-593.81%-1.55M
Depreciation and amortization
----
----
----
--0
----
----
----
----
193.74%11.96K
--0
Remuneration paid in stock
--0
-79.84%8.71K
-65.43%8.71K
--34.84K
93.10%-33.56K
--0
-37.05%43.2K
--25.2K
--0
-54,139.56%-486.36K
Other non cashItems
108.39%49.05K
655.80%66.79K
287.47%40.17K
-86.48%145.51K
-90.24%102.76K
32.48%23.54K
146.29%8.84K
457.12%10.37K
-62.38%1.08M
-31.58%1.05M
Change In working capital
-25.36%61.08K
-57.04%35.99K
67.78%-51.41K
-81.25%249.44K
-87.67%243.41K
129.95%81.83K
299.11%83.77K
51.28%-159.57K
249.96%1.33M
1,058.64%1.97M
-Change in receivables
-126.88%-55.85K
113.16%22.36K
-114.23%-95.57K
25.35%793.86K
-91.39%84.36K
111.28%207.74K
-15.83%-169.86K
325.05%671.62K
181.17%633.31K
237.47%980.07K
-Change in prepaid assets
----
----
----
----
----
----
----
3,837.82%64.03K
----
----
-Change in payables and accrued expense
170.52%126.07K
-146.80%-173.42K
104.93%44.16K
-178.08%-544.42K
-73.59%159.04K
-1,011.56%-178.78K
248.90%370.53K
-2,814.50%-895.22K
-40.99%697.25K
183.45%602.16K
-Change in other working capital
---9.14K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
84.00%-49.93K
17.01%-284.29K
141.47%267.1K
27.41%-1.64M
-130.26%-342.62K
73.99%-312.03K
71.53%-342.55K
34.97%-644K
22.22%-2.26M
236.76%1.13M
Investing cash flow
Cash flow from continuing investing activities
0
-35.79%-58.39K
Net business purchase and sale
----
----
----
--0
----
----
----
----
-358.46%-58.39K
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
----
----
----
----
-35.79%-58.39K
----
Financing cash flow
Cash flow from continuing financing activities
0
-85.59%50K
0
-28.73%1.28M
137.11%331.88K
-75.08%269.38K
-71.13%346.86K
-18.69%332.87K
-26.55%1.8M
-154.95%-894.41K
Net issuance payments of debt
--0
----
----
----
----
131.62%269.38K
----
----
----
----
Net common stock issuance
----
----
--0
--0
-151.91%-189.73K
--0
-91.79%76.86K
--112.87K
-27.64%2.05M
-80.01%365.52K
Net other financing activities
----
----
----
615.98%1.28M
----
----
----
-46.26%220K
34.65%-248.26K
-595.39%-1.4M
Cash from discontinued financing activities
Financing cash flow
--0
-85.59%50K
--0
-28.73%1.28M
137.11%331.88K
-75.08%269.38K
-71.13%346.86K
-18.69%332.87K
-26.55%1.8M
-154.95%-894.41K
Net cash flow
Beginning cash position
-22.47%67.39K
265.16%301.68K
-91.22%34.59K
-58.49%393.75K
-82.11%44.28K
-75.54%86.93K
-91.29%82.62K
-58.49%393.75K
-35.65%948.66K
16.48%247.46K
Current changes in cash
-17.07%-49.93K
-5,535.94%-234.29K
185.85%267.1K
30.97%-360.2K
-105.99%-10.74K
60.48%-42.65K
100.72%4.31K
-4,263.96%-311.13K
-3.85%-521.81K
-76.39%179.39K
Effect of exchange rate changes
----
----
----
103.15%1.04K
----
----
----
----
-43.69%-33.11K
----
End cash Position
-60.56%17.46K
-22.47%67.39K
265.16%301.68K
-91.22%34.59K
-91.22%34.59K
-82.11%44.28K
-75.54%86.93K
-91.29%82.62K
-58.49%393.75K
-58.49%393.75K
Free cash from
84.00%-49.93K
17.01%-284.29K
141.47%267.1K
27.41%-1.64M
-130.26%-342.62K
73.75%-312.03K
71.61%-342.55K
35.45%-644K
23.94%-2.26M
227.11%1.13M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 84.00%-49.93K17.01%-284.29K141.47%267.1K27.41%-1.64M-130.26%-342.62K73.99%-312.03K71.53%-342.55K34.97%-644K22.22%-2.26M236.76%1.13M
Net income from continuing operations 60.30%-160.06K17.26%-395.78K184.61%439.97K35.23%-2.03M-604.87%-632.85K70.39%-403.22K61.24%-478.36K22.43%-520K54.22%-3.14M105.07%125.35K
Operating gains losses --0--0---170.35K97.62%-36.56K-----------------592.34%-1.54M-593.81%-1.55M
Depreciation and amortization --------------0----------------193.74%11.96K--0
Remuneration paid in stock --0-79.84%8.71K-65.43%8.71K--34.84K93.10%-33.56K--0-37.05%43.2K--25.2K--0-54,139.56%-486.36K
Other non cashItems 108.39%49.05K655.80%66.79K287.47%40.17K-86.48%145.51K-90.24%102.76K32.48%23.54K146.29%8.84K457.12%10.37K-62.38%1.08M-31.58%1.05M
Change In working capital -25.36%61.08K-57.04%35.99K67.78%-51.41K-81.25%249.44K-87.67%243.41K129.95%81.83K299.11%83.77K51.28%-159.57K249.96%1.33M1,058.64%1.97M
-Change in receivables -126.88%-55.85K113.16%22.36K-114.23%-95.57K25.35%793.86K-91.39%84.36K111.28%207.74K-15.83%-169.86K325.05%671.62K181.17%633.31K237.47%980.07K
-Change in prepaid assets ----------------------------3,837.82%64.03K--------
-Change in payables and accrued expense 170.52%126.07K-146.80%-173.42K104.93%44.16K-178.08%-544.42K-73.59%159.04K-1,011.56%-178.78K248.90%370.53K-2,814.50%-895.22K-40.99%697.25K183.45%602.16K
-Change in other working capital ---9.14K------------------------------------
Cash from discontinued investing activities
Operating cash flow 84.00%-49.93K17.01%-284.29K141.47%267.1K27.41%-1.64M-130.26%-342.62K73.99%-312.03K71.53%-342.55K34.97%-644K22.22%-2.26M236.76%1.13M
Investing cash flow
Cash flow from continuing investing activities 0-35.79%-58.39K
Net business purchase and sale --------------0-----------------358.46%-58.39K----
Cash from discontinued investing activities
Investing cash flow --------------0-----------------35.79%-58.39K----
Financing cash flow
Cash flow from continuing financing activities 0-85.59%50K0-28.73%1.28M137.11%331.88K-75.08%269.38K-71.13%346.86K-18.69%332.87K-26.55%1.8M-154.95%-894.41K
Net issuance payments of debt --0----------------131.62%269.38K----------------
Net common stock issuance ----------0--0-151.91%-189.73K--0-91.79%76.86K--112.87K-27.64%2.05M-80.01%365.52K
Net other financing activities ------------615.98%1.28M-------------46.26%220K34.65%-248.26K-595.39%-1.4M
Cash from discontinued financing activities
Financing cash flow --0-85.59%50K--0-28.73%1.28M137.11%331.88K-75.08%269.38K-71.13%346.86K-18.69%332.87K-26.55%1.8M-154.95%-894.41K
Net cash flow
Beginning cash position -22.47%67.39K265.16%301.68K-91.22%34.59K-58.49%393.75K-82.11%44.28K-75.54%86.93K-91.29%82.62K-58.49%393.75K-35.65%948.66K16.48%247.46K
Current changes in cash -17.07%-49.93K-5,535.94%-234.29K185.85%267.1K30.97%-360.2K-105.99%-10.74K60.48%-42.65K100.72%4.31K-4,263.96%-311.13K-3.85%-521.81K-76.39%179.39K
Effect of exchange rate changes ------------103.15%1.04K-----------------43.69%-33.11K----
End cash Position -60.56%17.46K-22.47%67.39K265.16%301.68K-91.22%34.59K-91.22%34.59K-82.11%44.28K-75.54%86.93K-91.29%82.62K-58.49%393.75K-58.49%393.75K
Free cash from 84.00%-49.93K17.01%-284.29K141.47%267.1K27.41%-1.64M-130.26%-342.62K73.75%-312.03K71.61%-342.55K35.45%-644K23.94%-2.26M227.11%1.13M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.